Finding the best way to give an arthritis medication to help more patients

This trial is testing whether methotrexate given by weekly injection under the skin works better than taking it by mouth for rheumatoid arthritis patients whose disease is still active. Many people with rheumatoid arthritis don't get enough relief from oral methotrexate alone, and researchers want to understand if changing how the medication is delivered—or adjusting the dose—can help more patients before they need to switch to stronger drugs.

Methotrexate is the first medication doctors prescribe for rheumatoid arthritis, but a large number of patients don't achieve remission (where the disease quiets down) with the pill form alone. This trial exists to see if maximizing the medication's potential through different dosing and delivery methods could help more people avoid needing to switch to more expensive or intensive treatments.